NEVIRAPINE
- Product NDC
- 69097-403
- 11-digit product format
- 690970403
- Labeler code
- 69097
- Product ID
- 69097-403_def35264-15cf-4def-8558-c80af302b018
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NEVIRAPINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA206448
- Marketing category
- ANDA
- Marketing start
- 2015-10-15
- Marketing end
- 2019-12-31
- Substance
- NEVIRAPINE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record